Clotting state after cardioversion of atrial fibrillation: A haemostasis index could detect the relationship with the arrythmia duration

Thrombosis Journal

Volumn 3, Issue , 2005, Pages

  Hatzinikolaou Kotsakou, Eleni ^a   Kartasis, Zafirios ^a   Tziakas, Dimitrios ^a   Stakos, Dimitrios ^a   Hotidis, Athanasios ^a   Chalikias, Georgios ^a   Bourikas, Goergios ^a   Hatseras, Dimitrios I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Atrial fibrillation; Haemostatic markers

Indexed keywords

D DIMER;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMOGRAPHY; DISEASE DURATION; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPOTHESIS; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR; SINUS RHYTHM; STROKE; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 27444438385     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-3-2     Document Type: Article

References (24)

1. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hori N: Increased inta-cardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990, 16:377-80.
2. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J: Coagulation factors and the increased risk of stroke in non-valvular atrial fibrillation. Stroke 1990, 21:47-51.
3. Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch Neurol 1986, 43:71-84.
4. Wolf PA, Dawber TR, Emerson T Jr, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of Stroke: the Framingham Study. Neurology 1978, 28:973-7.
5. Sherman DG, Goldman L, Whiting RR, Jurgessen K, Kaste M, Easton JD: Thrombo-embolism in patiens with atrial fibrillation. Arch Neurol 1984, 41:708-10.
6. Petersen P, Godtfrredsen J: Embolic complication in paroxysmal atrial fibrillation. Stroke 1986, 17:622-6.
7. Takahashi N, Seki A, Imataka K, Fujii J: Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn Circ J 1981, 22:143-9.
8. Manning WJ, Silverman DI, Katz SE, et al.: Impaired left atrial mechanical function after cardioversion::relationship to the duration of atrial fibrillation. J Am Coll Cardiol 1994, 23:1535-40.
9. Lip GYH, Lowe GDO: Fibrin D-dimer: a useful clinical marker of thrombogenesis. Clin Sci 1995, 89:205-14.
10. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y: Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 2001, 65:788-792.
11. Lip GYH, Lip P, Zarifis J, Watson RD, Bareford D, Lqwe GD, Beevers DG: Fibrin D-dimer and thrombomodulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 1996, 94:425-431.
12. Becker DM, Philbrick JT, Bachhuder TL, Humphries JE: D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis? Arch Intern Med 1996, 156:939-946.
13. Currie MS, Krishna Rao KM, Blazer DG, Cohen HJ: Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers). J Am Geriatr Soc 1994, 42:738-42.
14. Hager K, Platt D: Fibrin degeneration product concentrations (D-dimers) in the course of aging. Gerontology 1995, 41:159-65.
15. Tardy B, Tardy-Poncet B, Viallon A, Lafond P, Page Y, Venet C, et al.: Evaluation of D-dimer Elisa test in elderly patients with suspected pulmonary embolism. Thromb Haemost 1998, 79:38-41.
16. Lowe GDO, Rumely A, Yarnell JWG, Sweetnam PM, Thomas HF: Fibrin D-dimer, von-Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease:the Caerphilly Study. Blood Coagulation and Fibrinolysis 1995, 6:156-157.
17. Woodburn K, Lowe G, Rumely A, Love J, Pollock J: Relation of hemostatic, fibrinolytic and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1955, 14:346-352.
18. Escoffre-Barbe M, Oger E, Leroyer C, Grimaux M, Le Moigne E, Nonent M, et al.: Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis. Am J Clin Pathol 1998, 109:748-53.
19. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N: Increased intracardiovascular clotting in patients with atrial fibrillation. J Am Coll Cardiol 1990, 16:377-80.
20. Lip GY: The prothrombotic state in atrial fibrillation new insights, more questions, and clear answers needed. Am Heart J 2000, 140:348-350.
21. Bounameaux H, Cirafici P, de Moerloose P, Shneider PA, Slosman D, Reber G, Unger PF: Measurement of D-Dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1991, 337:196-200.
22. Kelly J, Rudd A, Lewis R, Hunt BJ: Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Int Med 2002, 162:747-756.
23. Heppell RM, Berkin KE, McLenechan JM, Davies JA: Haemostatic and haemodynamic abnormalities associated with left atrial thrombus in non-rheumatic atrial fibrillation. Heart 1997, 77:407-411.
24. Lip Lip GYH, R umley A, Dunn FG, Lowe GDO: Plasma fibrinogen and fibrin D- dimer levels in atrial fibrillation: effect of cardioversion to sinus rhythm. Int J Cardiol 1995, 51:245-53.